Recent

Neufeld, Austria, February 25th, 2025 – Sanochemia Pharmazeutika today announced positive headline results of the pivotal phase III study PROSTAPROGRESS on Ferumoxtran (EudraCT 2018-004310-18), performed by SPL Medical B.V. (Nijmegen,…

Sanochemia Pharmazeutika continues to strengthen its position in medical imaging with the submission of an application for its liver-specific contrast agent in multiple European countries.

The registration initiative launched by Sanochemia Pharmazeutika in 2021, together with the continuously increasing market demand, has led to a record volume of orders.

Sanochemia Pharmazeutika secures exclusive licensing rights to a new MRI contrast agent based on ferumoxtran, that is in an advanced pivotal trial in clinical phase III and may be used to detect the smallest lymph node metastases in prostate cancer patients. The product is already deployed in the Netherlands within an authorized Named-Patient-Use-Program (Artsenverklaring).

Sanochemia Pharmazeutika is strengthening its position in the field of medical imaging with an exclusive product license for a MRI contrast agent based on iron-containing nanoparticles under the brand name Resotran®.

Sanochemia Pharmazeutika is taking the green transition as an opportunity and takes a leap towards sustainability with a new photovoltaic (PV) facility.

For Sanochemia, joint development with employees is an important cornerstone of entrepreneurial activities. It is therefore particularly gratifying that some of Sanochemia's apprentices were honored for their special achievements: In…

Sanochemia aims to continuously grow its business and step-up partnerships for the future. Joint development with partner companies and employees are seen an important cornerstone of Sanochemia´s entrepreneurial activities. In…

SANOCHEMIA Pharmazeutika continues its strong commitment in combating the pandemic and launches a cooperation with the Province of Burgenland and Haemo Pharma. To increase regional PCR testing capacities, a dedicated…

As a global Contract Development and Manufacturing Organization (CDMO), SANOCHEMIA provides a broad and high-quality offering with a "FULL-Service" concept for a long time. Customers and partners benefit from access…